# CSL Plasma, Inc. – FDA Inspection, Jan 5, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/dfbec216-fd8f-4d73-84f6-00d216cec834
Source feed: FDA_Inspections

> FDA inspection 1195425 of CSL Plasma, Inc., January 05, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195425
- Company Name: CSL Plasma, Inc.
- Inspection Date: 2023-01-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1025772 - 2017-09-08
- [FDA Inspection 805215 - 2012-10-19](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/a7976eea-faf4-4c02-af08-e932e8eed58e)

## Related Officers

- [Investigator](https://www.keypedia.com/people/paul-m-chefor/96bea4a8-b1ee-4870-ae8b-24794c67da21)

Company: https://www.keypedia.com/companies/csl-plasma-inc/6812f94e-6862-4f3c-bb59-2927a488e095

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d